Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.

Molecular cancer - 19 Jun 2006

Mattie Michael D, Benz Christopher C, Bowers Jessica, Sensinger Kelly, Wong Linda, Scott Gary K, Fedele Vita, Ginzinger David, Getts Robert, Haqq Chris

Abstract excerpt

BACKGROUND: Recent studies indicate that microRNAs (miRNAs) are mechanistically involved in the development of various human malignancies, suggesting that they represent a promising new class of cancer biomarkers. However, previously reported methods for measuring miRNA expression consume large amounts of tissue, prohibiting high-throughput miRNA profiling from typically small clinical samples such as excision or...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biopsy
Share to Genes, erbB-2

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to MicroRNAs

Share to Prostatic Neoplasms

Share to Receptors, Estrogen

Share to Reproducibility of Results

Share to Sensitivity and Specificity

Share to Tumor Cells, Cultured

Source

Open in PubMed Open full text

Identifiers

PMID: 16784538
DOI: 10.1186/1476-4598-5-24
PMCID: PMC1563474

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 11 closest

Optimized high-throughput microRNA expression profiling provides novel biomarker assessment of clinical prostate and breast cancer biopsies.PMID 16784538Read ↗

Application of a Clinical Whole-Transcriptome Assay for Staging and Prognosis of Prostate Cancer Diagnosed in Needle Core Biopsy SpecimensSemantic proximity Read ↗

miRNA Biomarkers in Prostate Cancer: Leveraging Machine Learning for Improved Diagnostic AccuracySemantic proximity Read ↗

MicroRNA Signature Helps Distinguish Early from Late Biochemical Failure in Prostate CancerSemantic proximity Read ↗

A Novel Quantitative Multiplex Tissue Immunoblotting for Biomarkers Predicts a Prostate Cancer Aggressive Phenotype.Semantic proximity Read ↗

Analytical validation of the Oncotype DX prostate cancer assay – a clinical RT-PCR assay optimized for prostate needle biopsiesSemantic proximity Read ↗

Gene expression analysis of prostate cancersSemantic proximity Read ↗

Correlation of miRNA Expression Profiling in Surgical Pathology Materials, with Ki-67, HER2, ER and PR in Breast Cancer PatientsSemantic proximity Read ↗

Heterogeneity of miRNA expression in localized prostate cancer with clinicopathological correlationsSemantic proximity Read ↗

Identification of differentially expressed microRNAs in human male breast cancerSemantic proximity Read ↗

Profiling and Verification of Gene Expression Patterns in Normal and Malignant Human Prostate Tissues by cDNA Microarray AnalysisSemantic proximity Read ↗

Extracellular microvesicle microRNAs, along with imaging metrics, improve detection of aggressive prostate cancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.